Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc at BMO Capital Markets Growth & ESG Conference Transcript

Dec 04, 2023 / NTS GMT
Release Date Price: $51.46 (-0.33%)
Konstantinos Biliouris
BMO Capital Markets Equity Research - Director & Biotechnology Analyst

Hello, everyone. Thanks for attending today's session. My name is Kostas Biliouris, and I am one of the biotech analysts here at BMO Capital Markets. It's a pleasure to have here with me the CEO of Ionis Pharmaceuticals, Brett Monia. And thank you, Brett. Thanks for joining us today. It's a great pleasure to have you here.

And maybe we can start with a high-level overview of the company, and then -- for those who are not familiar with Ionis, and then we can take it from there with more specific questions. Thank you.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Sounds great, Kostas. Thank you for the invitation to be here today. It's a pleasure to provide an update on the great progress we're making at Ionis.

So Ionis, for those that aren't that familiar with the company, we are a well-established biotech company, now nearly 34 years old. We were created to really pioneer a new way of discovering and delivering

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot